Samaritan Oncology Hematology 531 Washington St STE 1000, Watertown, NY 13601 (315)7887990 (phone), (315)7884248 (fax)
Education:
Medical School University of Maryland School of Medicine Graduated: 1980
Procedures:
Bone Marrow Biopsy Chemotherapy Vaccine Administration
Conditions:
Anemia Bacterial Pneumonia Benign Polyps of the Colon Bladder Cancer Cervical Cancer
Languages:
English
Description:
Dr. Romano graduated from the University of Maryland School of Medicine in 1980. He works in Watertown, NY and specializes in Medical Oncology. Dr. Romano is affiliated with Samaritan Medical Center.
Us Patents
Expression Of Cry3B Insecticidal Protein In Plants
The present invention discloses methods and compositions comprising a group of novel expression cassettes which provide significantly improved levels of accumulation of Coleopteran inhibitory Cry3B and Cry3B variant amino acid sequences when these are expressed in plants. The preferred embodiments of the invention provide at least up to ten fold higher levels of insect controlling protein relative to the highest levels obtained using prior compositions. In particular, transgenic maize expressing higher levels of a protein designed to exhibit increased toxicity toward Coleopteran pests deliver superior levels of insect protection and are less likely to sponsor development of populations of target insects that are resistant to the insecticidally active protein.
Expression Of Cry3B Insecticidal Protein In Plants
The present invention discloses methods and compositions comprising a group of novel expression cassettes which provide significantly improved levels of accumulation of Coleopteran inhibitory Cry3B and Cry3B variant amino acid sequences when these are expressed in plants. The preferred embodiments of the invention provide at least up to ten fold higher levels of insect controlling protein relative to the highest levels obtained using prior compositions. In particular, transgenic maize expressing higher levels of a protein designed to exhibit increased toxicity toward Coleopteran pests deliver superior levels of insect protection and are less likely to sponsor development of populations of target insects that are resistant to the insecticidally active protein.
Expression Of Cry3B Insecticidal Protein In Plants
The present invention discloses methods and compositions comprising a novel expression cassette providing significantly improved levels of accumulation of inhibitory Cry3B variant protein when expressed in maize plants. The preferred embodiments of the invention provide at least up to ten fold higher levels of insect controlling protein relative to the highest levels obtained using prior compositions. In particular, transgenic maize expressing higher levels of a protein designed to exhibit increased toxicity toward pests deliver superior levels of insect protection and are less likely to sponsor development of populations of target insects that are resistant to the insecticidally active protein.
Expression Of Cry3B Insecticidal Protein In Plants
The present invention discloses methods and compositions comprising a group of novel expression cassettes which provide significantly improved levels of accumulation of Coleopteran inhibitory Cry3B and Cry3B variant amino acid sequences when these are expressed in plants. The preferred embodiments of the invention provide at least up to ten fold higher levels of insect controlling protein relative to the highest levels obtained using prior compositions. In particular, transgenic maize expressing higher levels of a protein designed to exhibit increased toxicity toward Coleopteran pests deliver superior levels of insect protection and are less likely to sponsor development of populations of target insects that are resistant to the insecticidally active protein.
Expression Of Cry3B Insecticidal Protein In Plants
The present invention discloses methods and compositions comprising a group of novel expression cassettes which provide significantly improved levels of accumulation of inhibitory Cry3B and Cry3B variant amino acid sequences when these are expressed in plants. The preferred embodiments of the invention provide at least up to ten fold higher levels of insect controlling protein relative to the highest levels obtained using prior compositions. In particular, transgenic maize expressing higher levels of a protein designed to exhibit increased toxicity toward pests deliver superior levels of insect protection and are less likely to sponsor development of populations of target insects that are resistant to the insecticidally active protein.
Agricultural Law Business Law Health Care Law Intellectual Property Agriculture Biochemistry Biotechnology Genomics Molecular Biology Patent Preparation Patent Prosecution Pharmaceuticals
Education:
Harvard University, h.D University of Massachusetts, BS
Joseph F. Brandt Elementary School Hoboken NJ 1953-1961
Community:
William Askins, Barry Halloran, Carl Teyssen, Janice Stubin, Rosemarie Beers, Robert Slezak, Patrick Caufield, Patricia Gray, Edgar Nieter, Zoraida Quinones, Sharon Argueta